FDA OKs First Drug for Thyroid Eye Disease

]]>(MedPage Today) -- The FDA approved teprotumumab (Tepezza) on Tuesday for adults with thyroid eye disease, making it the only non-surgical, FDA-approved treatment for this potentially blinding condition.Teprotumumab is a fully human monoclonal...